Michelle Keefe has sold SYNH and made no open-market buys since May 2020

Michelle Keefe is a seasoned healthcare executive and former Chief Executive Officer of Syneos Health, Inc. (Nasdaq: SYNH), a global, fully integrated biopharmaceutical solutions organization.( She was appointed CEO and joined the company’s Board of Directors in April 2022, bringing more than 30 years of life sciences industry experience and a strong track record in commercial leadership and medical affairs.( At Syneos Health, she previously served as President, Medical Affairs and Commercial Solutions, where she helped drive double‑digit growth in the Commercial business and advanced the company’s digital, data, and analytics capabilities.( Her tenure as CEO marked a notable milestone, as she became one of the few women to lead a large, publicly traded contract research organization.(

Before joining Syneos Health, Keefe held senior roles across the healthcare and pharmaceutical sectors, including Global Group President and Chief Development Officer at Publicis Health, where she oversaw contract sales, medical affairs, and specialty agency operations.( Earlier in her career, she spent roughly two decades at Pfizer, rising to Regional President and designing commercial models for the U.S. primary care business unit, and served as Vice President of Market Development for the Visiting Nurse Service of New York.( Keefe is also active in industry leadership and governance, acting as executive sponsor of the Syneos Health DE&I Council and serving on the Healthcare Businesswomen’s Association Global Board of Directors.( She holds a Bachelor of Science in Marketing from Seton Hall University.(

Written by Perplexity from public sources.